SCHEMBL6251685

SCHEMBL6251685

O=C(O)N1CCC(c2cccc([AsH2])c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
KCNH2 Q12809 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
QDPR P09417 1/20 0.43
KMO O15229 1/20 0.43
SCD5 Q86SK9 3/20 0.42
SPR P35270 1/20 0.42
BACE1 P56817 1/20 0.42
TP53 P04637 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
HSD11B1 P28845 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1558037 0.83 DRD2 (0.58) QDPRDRD2
SCHEMBL1531725 0.81 KCNH2 (0.59) NPC1CA12CA1CA2CA7
SCHEMBL2637025 0.81 NPC1 (0.61) NPC1SCD5RAB9APARP10PARP14
SCHEMBL4615095 0.81 NPC1 (0.45) NPC1CA12CA1CA2CA7
SCHEMBL18585948 0.81 HDAC4 (0.50) NPC1KCNH2HRH3QDPRKMO
Hydrogen Sulfide SCHEMBL27863722 0.80 KCNH2 (0.58) NPC1CA12CA1CA2CA7
SCHEMBL17596063 0.79 DRD2 (0.50) NPC1RAB9AALDH1A1POLBDRD2
SCHEMBL2637036 0.78 DRD2 (0.59) QDPRRAB9AALDH1A1HSD11B1DRD2
SCHEMBL4405378 0.78 TPSAB1 (0.58) KCNH2
SCHEMBL1581482 0.78 DRD2 (0.58) POLBDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411942-A4 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMA CORP (US) 2005-01-26 EP disclosed
EP-1411942-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS Synaptic Pharmaceutical Corporation (US) 2004-04-28 EP disclosed
WO-2003004027-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2003-01-16 WO disclosed